Japan’s Itoham Sells Pharmaceutical Arm To Otsuka Firm
This article was originally published in PharmAsia News
Executive Summary
A major meat-processing firm in Japan says it is getting out of the API business, selling its Ito Life Sciences to Otsuka Chemical, part of Otsuka Pharmaceutical. Itoham Foods said the sale is set to take place Sept. 1 for nearly $15.8 million. The deal includes subsidiaries of Ito Life Sciences in China and North America that also produced raw materials for drugs. Itoham said the sale of its pharmaceutical businesses would allow it to concentrate solely on its foods business. (Click here for more - a subscription may be required